Targeted Phosphoinositide 3-Kinase-delta (PI3Kδ) Therapy Shows Signs of Ameliorating IgE-Mediated Disease in Activated PI3Kδ Syndrome

View at publisher
Authors: Maria Zhu, David Schwartz, Gülbû Uzel, Harris Richard Droghini
Cited by: 0

Fields of Study & Subjects

Immunodeficiency and Autoimmune Disorders Autoimmune and Inflammatory Disorders Research T-cell and B-cell Immunology

Publication details

Journal / source
Journal of Allergy and Clinical Immunology
Volume
157
Issue
2
Pages
AB93–AB93
Publication date
1 February 2026
Language
EN